Is Astria Therapeutics, Inc. (ATXS) a Buy, Sell, or Hold?
Astria Therapeutics, Inc.
NASDAQ:ATXS
$12.58 USD
$0 (0.0%)
- Volume
- 3.06M
- Average Volume
- 1.07M
- Market Capitalization
- $718.13M
- P/E Ratio
- -7.40
- Dividend Yield
- 0.00%
- Price Target
- $20.00
- Year High
- $13.29
- Year Low
- $3.56
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.78
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
28
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
51
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 3.38M
ATXS Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
ATXS Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Violin Jonathan | director | 2026-01-23 | D-Return | 11.35 | 2026-01-23 |
| Violin Jonathan | director | 2026-01-23 | D-Return | 3 | 2026-01-23 |
| Violin Jonathan | director | 2026-01-23 | D-Return | 9.18 | 2026-01-23 |
| Violin Jonathan | director | 2026-01-23 | D-Return | 0 | 2026-01-23 |
| Violin Jonathan | director | 2026-01-23 | D-Return | 12.24 | 2026-01-23 |
| Violin Jonathan | director | 2026-01-23 | D-Return | 5.79 | 2026-01-23 |
| Morabito Christopher | officer: Chief Medical Officer | 2026-01-23 | D-Return | 3.87 | 2026-01-23 |
| Morabito Christopher | officer: Chief Medical Officer | 2026-01-23 | D-Return | 6.41 | 2026-01-23 |
| Milne Jill C. | director, officer: CEO and President | 2026-01-23 | D-Return | 6.41 | 2026-01-23 |
| Milne Jill C. | director, officer: CEO and President | 2026-01-23 | D-Return | 0 | 2026-01-23 |
| Milne Jill C. | director, officer: CEO and President | 2026-01-23 | D-Return | 6.51 | 2026-01-23 |
| Matthews Andrea | officer: Chief Business Officer | 2026-01-23 | D-Return | 6.51 | 2026-01-23 |
| Matthews Andrea | officer: Chief Business Officer | 2026-01-23 | D-Return | 10.82 | 2026-01-23 |
| Matthews Andrea | officer: Chief Business Officer | 2026-01-23 | D-Return | 6.41 | 2026-01-23 |
| LAPOINTE ANTHONY GREGG | director | 2026-01-23 | D-Return | 11.35 | 2026-01-23 |
| LAPOINTE ANTHONY GREGG | director | 2026-01-23 | D-Return | 12.24 | 2026-01-23 |
| LAPOINTE ANTHONY GREGG | director | 2026-01-23 | D-Return | 9.18 | 2026-01-23 |
| LAPOINTE ANTHONY GREGG | director | 2026-01-23 | D-Return | 3 | 2026-01-23 |
| LAPOINTE ANTHONY GREGG | director | 2026-01-23 | D-Return | 5.79 | 2026-01-23 |
| Komjathy Andrew | officer: Chief Commercial Officer | 2026-01-23 | D-Return | 6.51 | 2026-01-23 |
| Komjathy Andrew | officer: Chief Commercial Officer | 2026-01-23 | D-Return | 6.41 | 2026-01-23 |
| Komjathy Andrew | officer: Chief Commercial Officer | 2026-01-23 | D-Return | 0 | 2026-01-23 |
| KISHBAUCH MICHAEL D | director | 2026-01-23 | D-Return | 12.24 | 2026-01-23 |
| KISHBAUCH MICHAEL D | director | 2026-01-23 | D-Return | 5.79 | 2026-01-23 |
| KISHBAUCH MICHAEL D | director | 2026-01-23 | D-Return | 11.35 | 2026-01-23 |
| KISHBAUCH MICHAEL D | director | 2026-01-23 | D-Return | 9.18 | 2026-01-23 |
| KISHBAUCH MICHAEL D | director | 2026-01-23 | D-Return | 3 | 2026-01-23 |
| Harshbarger Benjamin | officer: Chief Legal Officer | 2026-01-23 | D-Return | 12.96 | 2026-01-23 |
| Harshbarger Benjamin | officer: Chief Legal Officer | 2026-01-23 | D-Return | 6.51 | 2026-01-23 |
| Harshbarger Benjamin | officer: Chief Legal Officer | 2026-01-23 | D-Return | 6.41 | 2026-01-23 |
| Cole Hugh M | director | 2026-01-23 | D-Return | 3 | 2026-01-23 |
| Cole Hugh M | director | 2026-01-23 | D-Return | 5.79 | 2026-01-23 |
| Cole Hugh M | director | 2026-01-23 | D-Return | 11.35 | 2026-01-23 |
| Cole Hugh M | director | 2026-01-23 | D-Return | 12.24 | 2026-01-23 |
| Cole Hugh M | director | 2026-01-23 | D-Return | 9.18 | 2026-01-23 |
| Clauser Noah | officer: Chief Financial Officer | 2026-01-23 | D-Return | 6.51 | 2026-01-23 |
| Clauser Noah | officer: Chief Financial Officer | 2026-01-23 | D-Return | 6.41 | 2026-01-23 |
| Callori Fred | director | 2026-01-23 | D-Return | 11.35 | 2026-01-23 |
| Callori Fred | director | 2026-01-23 | D-Return | 3 | 2026-01-23 |
| Callori Fred | director | 2026-01-23 | D-Return | 9.18 | 2026-01-23 |
| Callori Fred | director | 2026-01-23 | D-Return | 12.24 | 2026-01-23 |
| Callori Fred | director | 2026-01-23 | D-Return | 5.79 | 2026-01-23 |
| Beck Joanne T. | director | 2026-01-23 | D-Return | 3 | 2026-01-23 |
| Beck Joanne T. | director | 2026-01-23 | D-Return | 12.24 | 2026-01-23 |
| Beck Joanne T. | director | 2026-01-23 | D-Return | 5.79 | 2026-01-23 |
| Beck Joanne T. | director | 2026-01-23 | D-Return | 9.18 | 2026-01-23 |
| Beck Joanne T. | director | 2026-01-23 | D-Return | 11.35 | 2026-01-23 |
| BATE KENNETH | director | 2026-01-23 | D-Return | 12.24 | 2026-01-23 |
| BATE KENNETH | director | 2026-01-23 | D-Return | 5.79 | 2026-01-23 |
| BATE KENNETH | director | 2026-01-23 | D-Return | 3 | 2026-01-23 |
| BATE KENNETH | director | 2026-01-23 | D-Return | 9.18 | 2026-01-23 |
| BATE KENNETH | director | 2026-01-23 | D-Return | 11.35 | 2026-01-23 |
| AGARWAL SUNIL | director | 2026-01-23 | D-Return | 11.4 | 2026-01-23 |
| AGARWAL SUNIL | director | 2026-01-23 | D-Return | 5.79 | 2026-01-23 |
| AGARWAL SUNIL | director | 2025-06-11 | A-Award | 5.79 | 2025-06-12 |
| BATE KENNETH | director | 2025-06-11 | A-Award | 5.79 | 2025-06-12 |
| Cole Hugh M | director | 2025-06-11 | A-Award | 5.79 | 2025-06-12 |
| KISHBAUCH MICHAEL D | director | 2025-06-11 | A-Award | 5.79 | 2025-06-12 |
| LAPOINTE ANTHONY GREGG | director | 2025-06-11 | A-Award | 5.79 | 2025-06-12 |
| Violin Jonathan | director | 2025-06-11 | A-Award | 5.79 | 2025-06-12 |
| Beck Joanne T. | director | 2025-06-11 | A-Award | 5.79 | 2025-06-12 |
| Callori Fred | director | 2025-06-11 | A-Award | 5.79 | 2025-06-12 |
| Milne Jill C. | director, officer: CEO and President | 2025-03-21 | A-Award | 6.41 | 2025-03-25 |
| Matthews Andrea | officer: Chief Business Officer | 2025-03-21 | A-Award | 6.41 | 2025-03-25 |
| Komjathy Andrew | officer: Chief Commercial Officer | 2025-03-21 | A-Award | 6.41 | 2025-03-25 |
| Harshbarger Benjamin | officer: Chief Legal Officer | 2025-03-21 | A-Award | 6.41 | 2025-03-25 |
| Clauser Noah | officer: Chief Financial Officer | 2025-03-21 | A-Award | 6.41 | 2025-03-25 |
| Morabito Christopher | officer: Chief Medical Officer | 2025-03-21 | A-Award | 6.41 | 2025-03-25 |
| LAPOINTE ANTHONY GREGG | director | 2024-06-05 | A-Award | 9.18 | 2024-06-06 |
| Beck Joanne T. | director | 2024-06-05 | A-Award | 9.18 | 2024-06-06 |
| Violin Jonathan | director | 2024-06-05 | A-Award | 9.18 | 2024-06-06 |
| Callori Fred | director | 2024-06-05 | A-Award | 9.18 | 2024-06-06 |
| KISHBAUCH MICHAEL D | director | 2024-06-05 | A-Award | 9.18 | 2024-06-06 |
| Cole Hugh M | director | 2024-06-05 | A-Award | 9.18 | 2024-06-06 |
| BATE KENNETH | director | 2024-06-05 | A-Award | 9.18 | 2024-06-06 |
| AGARWAL SUNIL | director | 2024-04-08 | A-Award | 11.4 | 2024-04-09 |
| AGARWAL SUNIL | director: | 2024-04-05 | 0 | 2024-04-09 | |
| Morabito Christopher | officer: Chief Medical Officer | 2024-04-01 | M-Exempt | 3.87 | 2024-04-03 |
| Morabito Christopher | officer: Chief Medical Officer | 2024-04-01 | M-Exempt | 3.87 | 2024-04-03 |
| Morabito Christopher | officer: Chief Medical Officer | 2024-04-01 | S-Sale | 13.5939 | 2024-04-03 |
| Morabito Christopher | officer: Chief Medical Officer | 2024-02-08 | A-Award | 15.26 | 2024-02-12 |
| Milne Jill C. | director, officer: CEO and President | 2024-02-08 | A-Award | 15.26 | 2024-02-12 |
| Matthews Andrea | officer: Chief Business Officer | 2024-02-08 | A-Award | 15.26 | 2024-02-12 |
| Komjathy Andrew | officer: Chief Commercial Officer | 2024-02-08 | A-Award | 15.26 | 2024-02-12 |
| Harshbarger Benjamin | officer: Chief Legal Officer | 2024-02-08 | A-Award | 15.26 | 2024-02-12 |
| Clauser Noah | officer: Chief Financial Officer | 2024-02-08 | A-Award | 15.26 | 2024-02-12 |
| PERCEPTIVE ADVISORS LLC | director | 2024-02-01 | P-Purchase | 12.09 | 2024-02-05 |
| Morabito Christopher | officer: Chief Medical Officer | 2024-01-26 | M-Exempt | 3.87 | 2024-01-30 |
| Morabito Christopher | officer: Chief Medical Officer | 2024-01-29 | M-Exempt | 3.87 | 2024-01-30 |
| Morabito Christopher | officer: Chief Medical Officer | 2024-01-29 | M-Exempt | 3.87 | 2024-01-30 |
| Morabito Christopher | officer: Chief Medical Officer | 2024-01-26 | M-Exempt | 3.87 | 2024-01-30 |
| Morabito Christopher | officer: Chief Medical Officer | 2024-01-29 | S-Sale | 11.147 | 2024-01-30 |
| Morabito Christopher | officer: Chief Medical Officer | 2024-01-26 | S-Sale | 11.015 | 2024-01-30 |
| PERCEPTIVE ADVISORS LLC | director | 2023-12-21 | P-Purchase | 6.2 | 2023-12-22 |
| PERCEPTIVE ADVISORS LLC | director | 2023-10-16 | P-Purchase | 6.514 | 2023-10-18 |
| PERCEPTIVE ADVISORS LLC | director | 2023-10-16 | P-Purchase | 6.514 | 2023-10-18 |
| PERCEPTIVE ADVISORS LLC | director | 2023-10-16 | P-Purchase | 8.025 | 2023-10-18 |
| PERCEPTIVE ADVISORS LLC | director | 2023-10-16 | P-Purchase | 0.001 | 2023-10-18 |
| PERCEPTIVE ADVISORS LLC | director | 2023-10-16 | P-Purchase | 8.025 | 2023-10-18 |
| PERCEPTIVE ADVISORS LLC | director | 2023-10-16 | P-Purchase | 8.025 | 2023-10-18 |